Imatinib resistance associated with BCR-ABL upregulation is dependent on HIF-1alpha-induced metabolic reprograming.
Zhao F; Mancuso A; Bui TV; Tong X; Gruber JJ; Swider CR; Sanchez PV; Lum JJ; Sayed N; Melo JV; Perl AE; Carroll M; Tuttle SW; Thompson CB; Oncogene, 2010, vol. 29, issue 20, p 2962, ISSN 14765594. ISBN 14765594.

Full Text Resources Located for this Citation

View article on EBSCOhost(Login required)
View article via CrossRef